A real-world study of polyenyl phosphatidylcholine in the management of patients with metabolic dysfunction-associated fatty liver disease in China clinical practice.

Front Med (Lausanne) · 2025 · PMC12457410 · PMID 41001365

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The PPC group showed a decreasing trend in baseline ALT levels at 12- and 24-weeks vs. control group, although this difference was not statistically significant ( Figure 3 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.